Gianpietro Dotti, MD, is director of the Immunotherapy Program at the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center and professor in the Department of Microbiology and Immunology at UNC-Chapel Hill.
Dr. Dotti has studied immunotherapy strategies to treat patients with hematologic malignancies including lymphomas and leukemia and solid tumors such as neuroblastoma. He has also been involved in developing chimeric antigen receptor (CAR)-based strategies to target solid tumors such as neuroblastoma in pediatric patients and triple negative breast cancer in adult patients. A significant focus of Dotti’s research is the development of strategies of T cell engineering aimed at overcoming immune suppressive mechanisms of the tumor microenvironment.
He received his medical degree from the University of Milan in Italy with further training in hematology from the University of Parma and a post-doctoral fellowship from Baylor College of Medicine in Houston.